{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T18:14:34Z","timestamp":1751480074631},"reference-count":46,"publisher":"Nofer Institute of Occupational Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>","DOI":"10.2478\/s13382-011-0044-9","type":"journal-article","created":{"date-parts":[[2011,11,15]],"date-time":"2011-11-15T23:09:33Z","timestamp":1321398573000},"source":"Crossref","is-referenced-by-count":8,"title":["Effect of regular physical activity on non-lipid (novel) cardiovascular risk factors"],"prefix":"10.13075","volume":"24","author":[{"given":"Mohammad","family":"Naghii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mraryam","family":"Aref","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Almadadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Hedayati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5258","reference":[{"key":"44_CR1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/14017430802276114","volume":"42","author":"D.S. Thelle","year":"2008","unstructured":"Thelle DS. The causal role of blood lipids in the aetiology of coronary heart disease-an epidemiologist\u2019s perspective. Scand Cardiovasc J 2008;42:274\u2013278.","journal-title":"Scand Cardiovasc J"},{"key":"44_CR2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2174\/092986709787002754","volume":"16","author":"S. Greenfeder","year":"2009","unstructured":"Greenfeder S. Emerging strategies and agents to lower cardiovascular risk by increasing high density lipoprotein cholesterol levels. Curr Med Chem 2009;16:144\u2013156.","journal-title":"Curr Med Chem"},{"key":"44_CR3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2147\/vhrm.1.2.119.64083","volume":"1","author":"G.D. Norata","year":"2005","unstructured":"Norata GD, Catapano AL. Molecular mechanisms responsible for the antiinflammatory and protective effect of HDL on the endothelium. Vasc Health Risk Manag 2005;1:119\u2013129.","journal-title":"Vasc Health Risk Manag"},{"key":"44_CR4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","volume":"110","author":"S.M. Grundy","year":"2004","unstructured":"Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227\u2013239.","journal-title":"Circulation"},{"key":"44_CR5","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/jama.298.7.786","volume":"298","author":"I.M. Singh","year":"2007","unstructured":"Singh IM, Shishehbor MH, Ansell BJ. High-density lipoprotein as atherapeutic target: asystematic review. JAMA 2007;298: 786\u2013798.","journal-title":"JAMA"},{"key":"44_CR6","first-page":"483","volume":"56","author":"E. Powers","year":"2007","unstructured":"Powers E, Saultz J, Hamilton A, Lo V. Clinical inquiries. Which lifestyle interventions effectively lower LDL cholesterol? J Fam Pract 2007;56:483\u2013485.","journal-title":"J Fam Pract"},{"key":"44_CR7","doi-asserted-by":"crossref","first-page":"560.e1","DOI":"10.1016\/j.ahj.2007.06.029","volume":"154","author":"K.A. Volaklis","year":"2007","unstructured":"Volaklis KA, Spassis AT, Tokmakidis SP. Land versus water exercise in patients with coronary artery disease: effects on body composition, blood lipids, and physical fitness. Am Heart J 2007;154:560.e1\u20136.","journal-title":"Am Heart J"},{"key":"44_CR8","volume-title":"National Institutes of Health (NIH) Publication No. 06-3680","author":"National Institute of DiabetesDigestiveKidney Disease.","year":"2008","unstructured":"National Institute of Diabetes and Digestive and Kidney Disease. Understanding Adult Obesity. National Institutes of Health (NIH) Publication No. 06-3680. November 2008. Bethesda, MD.: U.S. Department of Health and Human Services; 2008. [2011 June 13]. Available from URL: http:\/\/win.niddk.nih.gov\/publications\/understanding.htm ."},{"key":"44_CR9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/01.CIR.0000151788.08740.5C","volume":"111","author":"A.S. Leon","year":"2005","unstructured":"Leon AS, Franklin BA, Costa F, Balady GJ, Berra KA, Stewart KJ, et al. Cardiac rehabilitation and secondary prevention of coronary heart disease: an American Heart Association scientific statement from the Council on Clinical Cardiology. Circulation 2005;111:369\u2013376.","journal-title":"Circulation"},{"key":"44_CR10","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/CIRCULATIONAHA.106.174516","volume":"113","author":"S.C. Smith Jr","year":"2006","unstructured":"Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, et al. AHA\/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006;113:2363\u20132372.","journal-title":"Circulation"},{"key":"44_CR11","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(06)68770-9","volume":"367","author":"A.D. Lopez","year":"2006","unstructured":"Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367:1747\u20131757.","journal-title":"Lancet"},{"key":"44_CR12","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(03)12655-4","volume":"361","author":"C.J. Murray","year":"2003","unstructured":"Murray CJ, Lauer JA, Hutubessy RC, Niessen L, Tomijima N, Rodgers A, et al. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet 2003;361:717\u2013725.","journal-title":"Lancet"},{"key":"44_CR13","volume-title":"The Atlas of Heart Disease and Stroke","author":"J. Mackay","year":"2004","unstructured":"Mackay J, Mensah G. The Atlas of Heart Disease and Stroke. Geneva: World Health Organization; 2004[2011 June 13]. Available from URL: http:\/\/www.who.int\/cardiovascular_diseases\/resources\/atlas\/en\/index.html"},{"key":"44_CR14","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/jama.290.7.898","volume":"290","author":"U.N. Khot","year":"2003","unstructured":"Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 2003;290:898\u2013904.","journal-title":"JAMA"},{"key":"44_CR15","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1001\/jama.293.15.1868","volume":"293","author":"E.W. Gregg","year":"2005","unstructured":"Gregg EW, Cheng YJ, Cadwell BL, Imperatore G, Williams DE, Flegal KM, et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA 2005;293:1868\u20131874.","journal-title":"JAMA"},{"key":"44_CR16","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jacc.2005.07.006","volume":"46","author":"P. Libby","year":"2005","unstructured":"Libby P. The forgotten majority: unfinished business in cardiovascular risk reduction. J Am Coll Cardiol 2005;46:1225\u20131228.","journal-title":"J Am Coll Cardiol"},{"key":"44_CR17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/bmj.39063.689375.55","volume":"334","author":"C.L. Gillies","year":"2007","unstructured":"Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 2007;334:299.","journal-title":"BMJ"},{"key":"44_CR18","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1161\/CIRCULATIONAHA.106.655688","volume":"114","author":"V.J. Dzau","year":"2006","unstructured":"Dzau VJ, Antman EM, Black HR, Hayes DL, Manson JE, Plutzky J, et al. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease). Circulation 2006;114:2850\u20132870.","journal-title":"Circulation"},{"key":"44_CR19","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1249\/mss.0b013e3180616b27","volume":"39","author":"W.L. Haskell","year":"2007","unstructured":"Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 2007;39:1423\u20131434.","journal-title":"Med Sci Sports Exerc"},{"key":"44_CR20","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1161\/CIRCULATIONAHA.107.729939","volume":"116","author":"S. Mora","year":"2007","unstructured":"Mora S, Cook N, Buring JE, Ridker PM, Lee IM. Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms. Circulation 2007;116:2110\u20132118.","journal-title":"Circulation"},{"key":"44_CR21","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1161\/01.CIR.0000020650.86137.84","volume":"105","author":"S.M. Grundy","year":"2002","unstructured":"Grundy SM. Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation 2002;105:2696\u20132698.","journal-title":"Circulation"},{"key":"44_CR22","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1161\/01.CIR.0000131511.50734.44","volume":"109","author":"R. Carmena","year":"2004","unstructured":"Carmena R, Duriez P, Fruchart JC. Atherogenic lipoprotein particles in atherosclerosis. Circulation 2004;109:1112\u20131117.","journal-title":"Circulation"},{"key":"44_CR23","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/09513590701554306","volume":"23","author":"K. Guzelmeric","year":"2007","unstructured":"Guzelmeric K, Alkan N, Pirimoglu M, Unal O, Turan C. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome. Gynecol Endocrinol 2007;23:505\u2013510.","journal-title":"Gynecol Endocrinol"},{"key":"44_CR24","first-page":"156","volume":"61","author":"R.A. Karatela","year":"2009","unstructured":"Karatela RA, Sainani GS. Plasma homocysteine in obese, overweight and normal weight hypertensives and normotensives. Indian Heart J 2009;61:156\u2013159.","journal-title":"Indian Heart J"},{"key":"44_CR25","first-page":"199","volume":"11","author":"M. Alipour","year":"2007","unstructured":"Alipour M, Sohrabi D, Falah R, Heydarpour F, Mohammadi M. Effect of aerobic moderate exercise intensity and 15-F21-isoprostane concentrations in high cholesterol diet-induced atherosclerosis. Physiol Pharmacol 2007;11:199\u2013207.","journal-title":"Physiol Pharmacol"},{"key":"44_CR26","first-page":"26","volume":"3","author":"D. Soysal","year":"2003","unstructured":"Soysal D, Sava\u015f S, Susam I, Cevik C, G\u00f6ldeli E, S\u00f6zmen E, et al. The association of plasma homocysteine, coronary risk factors and serum nitrite in patients with coronary artery disease, vascular syndrome x and healthy subjects. Anadolu Kardiyol Derg 2003;3:26\u201334.","journal-title":"Anadolu Kardiyol Derg"},{"key":"44_CR27","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1515\/CCLM.2007.358","volume":"45","author":"D. Liao","year":"2007","unstructured":"Liao D, Yang X, Wang H. Hyperhomocysteinemia and high-density lipoprotein metabolism in cardiovascular disease. Clin Chem Lab Med 2007;45:1652\u20131659.","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"44_CR28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.numecd.2009.08.003","volume":"21","author":"J. Yun","year":"2011","unstructured":"Yun J, Kim JY, Kim OY, et al. Associations of plasma homocysteine level with brachial-ankle pulse wave velocity and inflammation profile in healthy men. Nutr Metab Cardiovasc Dis 2011;21(2):136\u2013143.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"44_CR29","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/01.RES.0000242559.42077.22","volume":"99","author":"D. Liao","year":"2006","unstructured":"Liao D, Tan H, Hui R, Li Z, Jiang X, Gaubatz J, et al. Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance. Circ Res 2006;99:598\u2013606.","journal-title":"Circ Res"},{"key":"44_CR30","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.2010.840","volume":"303","author":"J.M. Armitage","year":"2010","unstructured":"Armitage JM, Bowman L, Clarke RJ, Wallendszus K, Bulbulia R, Rahimi K, et al. Effect of homocysteine-lowering with folic acid plus vitamin B12 vs. placebo on mortality and major morbidity in myocardial infarction survivors. JAMA 2010;303:2486\u20132494.","journal-title":"JAMA"},{"issue":"2","key":"44_CR31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00592-009-0171-y","volume":"48","author":"S.C. Su","year":"2011","unstructured":"Su SC, Pei D, Hsieh CH, Hsiao FC, Wu CZ, Hung YJ. Circulating pro-inflammatory cytokines and adiponectin in young men with type2 diabetes. Acta Diabetol 2011;48(2):113\u2013119.","journal-title":"Acta Diabetol"},{"key":"44_CR32","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1111\/j.1743-6109.2009.01473.x","volume":"7","author":"S.A. Moreno","year":"2010","unstructured":"Moreno SA, Shyam A, Morgentaler A. Comparison of free testosterone results by analog radioimmunoassay and calculated free testosterone in an ambulatory clinical population. J Sex Med 2010;7:1948\u20131953.","journal-title":"J Sex Med"},{"key":"44_CR33","first-page":"1260","volume":"26","author":"D.A. Al-Qahtani","year":"2005","unstructured":"Al-Qahtani DA, Imtiaz ML, Shareef MM. Obesity and cardiovascular risk factors in Saudi adult soldiers. Saudi Med J 2005;26:1260\u20131268.","journal-title":"Saudi Med J"},{"key":"44_CR34","first-page":"1360","volume":"26","author":"D.A. Al-Qahtani","year":"2005","unstructured":"Al-Qahtani DA, Imtiaz ML. Prevalence of metabolic syndrome in Saudi adult soldiers. Saudi Med J 2005;26:1360\u20131366.","journal-title":"Saudi Med J"},{"key":"44_CR35","doi-asserted-by":"crossref","first-page":"968","DOI":"10.3357\/ASEM.2097.2007","volume":"78","author":"N.S. Khazale","year":"2007","unstructured":"Khazale NS, Haddad F. Prevalence and characteristics of metabolic syndrome in 111 Royal Jordanian Air Force pilots. Aviat Space Environ Med 2007;78:968\u2013972.","journal-title":"Aviat Space Environ Med"},{"key":"44_CR36","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.diabres.2006.09.019","volume":"76","author":"I. Mikkola","year":"2007","unstructured":"Mikkola I, Kein\u00e4nen-Kiukaanniemi S, Laakso M, Jokelainen J, H\u00e4rk\u00f6nen P, Meyer-Rochow VB, et al. Metabolic syndrome in connection with BMI in young Finnish male adults. Diabetes Res Clin Pract 2007;76:404\u2013409.","journal-title":"Diabetes Res Clin Pract"},{"key":"44_CR37","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1157\/13091368","volume":"59","author":"M. Laclaustra-Gimeno","year":"2006","unstructured":"Laclaustra-Gimeno M, Gonz\u00e1lez-Garc\u00eda MP, Casasnovas-Lenguas JA, Luengo-Fern\u00e1ndez E, Le\u00f3n-Latre M, Portero-P\u00e9rez P, et al. Cardiovascular risk factor progression in young males at 15-year follow-up in the General Military Academy of Zaragoza (AGEMZA) Study. Rev Esp Cardiol 2006;59: 671\u2013678.","journal-title":"Rev Esp Cardiol"},{"issue":"6Suppl","key":"44_CR38","doi-asserted-by":"crossref","first-page":"S502","DOI":"10.1097\/00005768-200106001-00021","volume":"33","author":"A.S. Leon","year":"2001","unstructured":"Leon AS, Sanchez OA. Response of blood lipids to exercise training alone or combined with dietary intervention. Med Sci Sports Exerc 2001;33(6 Suppl):S502\u2013S515.","journal-title":"Med Sci Sports Exerc"},{"key":"44_CR39","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1001\/jama.290.10.1323","volume":"290","author":"J.M. Jakicic","year":"2003","unstructured":"Jakicic JM, Marcus BH, Gallagher KI, Napolitano M, Lang W. Effect of exercise duration and intensity on weight loss in overweight, sedentary women: arandomized trial. JAMA 2003;290:1323\u20131330.","journal-title":"JAMA"},{"key":"44_CR40","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1161\/01.CIR.0000075572.40158.77","volume":"107","author":"P.D. Thompson","year":"2003","unstructured":"Thompson PD, Buchner D, Pina IL, Balady GJ, Williams MA, Marcus BH, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation 2003;107:3109\u20133116.","journal-title":"Circulation"},{"key":"44_CR41","unstructured":"Norton L. Vigorous physical activity for 40 days may reduce cardiovascular risk factors. Abstract 747. American College of Sports Medicine (ACSM) 55th Annual Meeting; 2008 May 28\u201331, Indianapolis, USA. Medscape Medical News, 2008 [2011 June 13]. Available from: http:\/\/www.medscape.com\/viewarticle\/575585 ."},{"key":"44_CR42","first-page":"1209","volume":"56","author":"Centers for Disease ControlPrevention","year":"2007","unstructured":"Centers for Disease Control and Prevention (CDC). Prevalence of regular physical activity among adults-United States, 2001 and 2005. MMWR Morb Mortal Wkly Rep 2007;56:1209\u20131212.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"44_CR43","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","volume":"111","author":"M.B. Pepys","year":"2003","unstructured":"Pepys MB, Hirschfield GM. C-reactive protein: acritical update. J Clin Invest 2003;111:1805\u20131812.","journal-title":"J Clin Invest"},{"key":"44_CR44","doi-asserted-by":"crossref","first-page":"H2031","DOI":"10.1152\/ajpheart.01058.2004","volume":"288","author":"D.C. Lau","year":"2005","unstructured":"Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol 2005;288:H2031\u2013H2041.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"44_CR45","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.amjcard.2011.01.048","volume":"107","author":"J.H. Lee","year":"2011","unstructured":"Lee JH, Gadi R, Spertus JA, Tang F, O\u2019Keefe JH. Prevalence of vitamin D deficiency in patients with acute myocardial infarction. Am J Cardiol2011;107:1636\u20131638.","journal-title":"Am J Cardiol"},{"key":"44_CR46","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4065\/mcp.2010.0567","volume":"86","author":"T.D. Thacher","year":"2011","unstructured":"Thacher TD, Clarke BL. Vitamin D insufficiency. Mayo Clin Proc 2011;86:50\u201360.","journal-title":"Mayo Clin Proc"}],"container-title":["International Journal of Occupational Medicine and Environmental Health"],"original-title":[],"link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.2478\/s13382-011-0044-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T09:12:58Z","timestamp":1578042778000},"score":1,"resource":{"primary":{"URL":"http:\/\/ijomeh.eu\/Effect-of-regular-physical-activity-on-non-lipid-novel-cardiovascular-risk-factors,2290,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,1]]},"references-count":46,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.2478\/s13382-011-0044-9","relation":{},"ISSN":["1896-494X"],"issn-type":[{"value":"1896-494X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,1]]}}}